vs

Side-by-side financial comparison of GRAFTECH INTERNATIONAL LTD (EAF) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $125.1M, roughly 1.6× GRAFTECH INTERNATIONAL LTD). REPLIGEN CORP runs the higher net margin — 6.7% vs -34.6%, a 41.3% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 11.9%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-27.1M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -4.6%).

GrafTech International Ltd. is a manufacturer of graphite electrodes and petroleum coke, which are essential for the production of electric arc furnace steel and other metals. Headquartered in Brooklyn Heights, Ohio, it has manufacturing facilities in Calais, France;Pamplona, Spain; Monterrey, Mexico; and St. Marys, Pennsylvania.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

EAF vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.6× larger
RGEN
$197.9M
$125.1M
EAF
Growing faster (revenue YoY)
RGEN
RGEN
+1.8% gap
RGEN
13.6%
11.9%
EAF
Higher net margin
RGEN
RGEN
41.3% more per $
RGEN
6.7%
-34.6%
EAF
More free cash flow
RGEN
RGEN
$44.6M more FCF
RGEN
$17.6M
$-27.1M
EAF
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-4.6%
EAF

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EAF
EAF
RGEN
RGEN
Revenue
$125.1M
$197.9M
Net Profit
$-43.3M
$13.3M
Gross Margin
-7.8%
52.5%
Operating Margin
9.0%
Net Margin
-34.6%
6.7%
Revenue YoY
11.9%
13.6%
Net Profit YoY
-10.0%
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EAF
EAF
RGEN
RGEN
Q1 26
$125.1M
Q4 25
$116.5M
$197.9M
Q3 25
$144.0M
$188.8M
Q2 25
$131.8M
$182.4M
Q1 25
$111.8M
$169.2M
Q4 24
$134.2M
$174.1M
Q3 24
$130.7M
$154.9M
Q2 24
$137.3M
$154.1M
Net Profit
EAF
EAF
RGEN
RGEN
Q1 26
$-43.3M
Q4 25
$-65.1M
$13.3M
Q3 25
$-28.5M
$14.9M
Q2 25
$-86.9M
$14.9M
Q1 25
$-39.4M
$5.8M
Q4 24
$-49.5M
$-30.3M
Q3 24
$-36.1M
$-654.0K
Q2 24
$-14.8M
$3.3M
Gross Margin
EAF
EAF
RGEN
RGEN
Q1 26
-7.8%
Q4 25
-20.9%
52.5%
Q3 25
7.2%
53.2%
Q2 25
0.0%
50.0%
Q1 25
-1.5%
53.6%
Q4 24
-7.8%
26.1%
Q3 24
-9.2%
50.0%
Q2 24
2.9%
49.8%
Operating Margin
EAF
EAF
RGEN
RGEN
Q1 26
Q4 25
-33.6%
9.0%
Q3 25
-3.6%
8.9%
Q2 25
-11.0%
7.6%
Q1 25
-16.3%
3.9%
Q4 24
-18.6%
-17.7%
Q3 24
-20.1%
-5.1%
Q2 24
-2.0%
1.0%
Net Margin
EAF
EAF
RGEN
RGEN
Q1 26
-34.6%
Q4 25
-55.9%
6.7%
Q3 25
-19.8%
7.9%
Q2 25
-65.9%
8.2%
Q1 25
-35.2%
3.4%
Q4 24
-36.9%
-17.4%
Q3 24
-27.6%
-0.4%
Q2 24
-10.7%
2.2%
EPS (diluted)
EAF
EAF
RGEN
RGEN
Q1 26
Q4 25
$-6.86
$0.24
Q3 25
$-1.10
$0.26
Q2 25
$-0.34
$0.26
Q1 25
$-0.15
$0.10
Q4 24
$-3.51
$-0.55
Q3 24
$-1.40
$-0.01
Q2 24
$-0.06
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EAF
EAF
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$120.2M
$767.6M
Total DebtLower is stronger
$1.1B
$542.2M
Stockholders' EquityBook value
$2.1B
Total Assets
$997.2M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EAF
EAF
RGEN
RGEN
Q1 26
$120.2M
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$120.7M
$809.1M
Total Debt
EAF
EAF
RGEN
RGEN
Q1 26
$1.1B
Q4 25
$1.1B
$542.2M
Q3 25
$1.1B
$537.9M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
$525.6M
Q3 24
$929.5M
Q2 24
$928.2M
Stockholders' Equity
EAF
EAF
RGEN
RGEN
Q1 26
Q4 25
$-259.6M
$2.1B
Q3 25
$-194.4M
$2.1B
Q2 25
$-168.4M
$2.1B
Q1 25
$-105.3M
$2.0B
Q4 24
$-78.9M
$2.0B
Q3 24
$-9.0M
$2.0B
Q2 24
$16.2M
$2.0B
Total Assets
EAF
EAF
RGEN
RGEN
Q1 26
$997.2M
Q4 25
$1.0B
$2.9B
Q3 25
$1.1B
$2.9B
Q2 25
$1.1B
$2.9B
Q1 25
$1.2B
$2.9B
Q4 24
$1.2B
$2.8B
Q3 24
$1.1B
$2.8B
Q2 24
$1.2B
$2.9B
Debt / Equity
EAF
EAF
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
57.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EAF
EAF
RGEN
RGEN
Operating Cash FlowLast quarter
$-14.9M
$25.7M
Free Cash FlowOCF − Capex
$-27.1M
$17.6M
FCF MarginFCF / Revenue
-21.6%
8.9%
Capex IntensityCapex / Revenue
9.7%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-105.1M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EAF
EAF
RGEN
RGEN
Q1 26
$-14.9M
Q4 25
$-20.9M
$25.7M
Q3 25
$24.7M
$48.1M
Q2 25
$-53.2M
$28.6M
Q1 25
$-32.2M
$15.0M
Q4 24
$-26.4M
$39.2M
Q3 24
$23.7M
$49.3M
Q2 24
$-36.9M
$42.2M
Free Cash Flow
EAF
EAF
RGEN
RGEN
Q1 26
$-27.1M
Q4 25
$-39.3M
$17.6M
Q3 25
$18.4M
$43.4M
Q2 25
$-57.1M
$21.5M
Q1 25
$-42.5M
$11.4M
Q4 24
$-39.2M
$33.6M
Q3 24
$19.7M
$42.3M
Q2 24
$-43.8M
$37.4M
FCF Margin
EAF
EAF
RGEN
RGEN
Q1 26
-21.6%
Q4 25
-33.7%
8.9%
Q3 25
12.8%
23.0%
Q2 25
-43.3%
11.8%
Q1 25
-38.0%
6.8%
Q4 24
-29.2%
19.3%
Q3 24
15.1%
27.3%
Q2 24
-31.9%
24.3%
Capex Intensity
EAF
EAF
RGEN
RGEN
Q1 26
9.7%
Q4 25
15.8%
4.1%
Q3 25
4.4%
2.5%
Q2 25
3.0%
3.9%
Q1 25
9.2%
2.1%
Q4 24
9.5%
3.2%
Q3 24
3.1%
4.5%
Q2 24
5.1%
3.1%
Cash Conversion
EAF
EAF
RGEN
RGEN
Q1 26
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons